img

Global Biomarker Testing Market Size, Status and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 88 | Industry : Pharma & Healthcare

Publisher : q | Format : PDF

Global Biomarker Testing Market Size, Status and Forecast 2024-2034

Global Biomarker Testing Scope and Market Size
Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sepsis Biomarkers
Antibiotic Resistance Biomarkers
Traumatic Brain Injury (TBI) Testing Biomarkers
Stroke Testing Biomarkers
Antibiotic Stewardship Biomarkers
Others


Segment by Application


Hospital
Diagnostic Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA




By Company


Agilent Technologies
Roche

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Others
1.3 Market by Application
1.3.1 Global Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biomarker Testing Market Perspective (2016-2027)
2.2 Biomarker Testing Growth Trends by Regions
2.2.1 Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Biomarker Testing Industry Dynamic
2.3.1 Biomarker Testing Market Trends
2.3.2 Biomarker Testing Market Drivers
2.3.3 Biomarker Testing Market Challenges
2.3.4 Biomarker Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biomarker Testing Players by Revenue
3.1.1 Global Top Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biomarker Testing Revenue
3.4 Global Biomarker Testing Market Concentration Ratio
3.4.1 Global Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Testing Revenue in 2020
3.5 Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Biomarker Testing Product Solution and Service
3.7 Date of Enter into Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Testing Breakdown Data by Type
4.1 Global Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 Biomarker Testing Breakdown Data by Application
5.1 Global Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biomarker Testing Market Size (2016-2027)
6.2 North America Biomarker Testing Market Size by Type
6.2.1 North America Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America Biomarker Testing Market Size by Type (2016-2027)
6.3 North America Biomarker Testing Market Size by Application
6.3.1 North America Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Biomarker Testing Market Size by Country
6.4.1 North America Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Biomarker Testing Market Size (2016-2027)
7.2 Europe Biomarker Testing Market Size by Type
7.2.1 Europe Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe Biomarker Testing Market Size by Application
7.3.1 Europe Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Biomarker Testing Market Size by Country
7.4.1 Europe Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biomarker Testing Market Size (2016-2027)
9.2 Latin America Biomarker Testing Market Size by Type
9.2.1 Latin America Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America Biomarker Testing Market Size by Application
9.3.1 Latin America Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Biomarker Testing Market Size by Country
9.4.1 Latin America Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Biomarker Testing Introduction
11.1.4 Agilent Technologies Revenue in Biomarker Testing Business (2016-2021)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Biomarker Testing Introduction
11.2.4 Roche Revenue in Biomarker Testing Business (2016-2021)
11.2.5 Roche Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sepsis Biomarkers
Table 3. Key Players of Antibiotic Resistance Biomarkers
Table 4. Key Players of Traumatic Brain Injury (TBI) Testing Biomarkers
Table 5. Key Players of Stroke Testing Biomarkers
Table 6. Key Players of Antibiotic Stewardship Biomarkers
Table 7. Key Players of Others
Table 8. Global Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Biomarker Testing Market Share by Regions (2016-2021)
Table 12. Global Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Biomarker Testing Market Share by Regions (2022-2027)
Table 14. Biomarker Testing Market Trends
Table 15. Biomarker Testing Market Drivers
Table 16. Biomarker Testing Market Challenges
Table 17. Biomarker Testing Market Restraints
Table 18. Global Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Biomarker Testing Market Share by Players (2016-2021)
Table 20. Global Top Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Testing as of 2020)
Table 21. Ranking of Global Top Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Biomarker Testing Product Solution and Service
Table 25. Date of Enter into Biomarker Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Biomarker Testing Revenue Market Share by Type (2016-2021)
Table 29. Global Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 33. Global Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 65. Agilent Technologies Company Details
Table 66. Agilent Technologies Business Overview
Table 67. Agilent Technologies Biomarker Testing Product
Table 68. Agilent Technologies Revenue in Biomarker Testing Business (2016-2021) & (US$ Million)
Table 69. Agilent Technologies Recent Development
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Biomarker Testing Product
Table 73. Roche Revenue in Biomarker Testing Business (2016-2021) & (US$ Million)
Table 74. Roche Recent Development
Table 75. Research Programs/Design for This Report
Table 76. Key Data Information from Secondary Sources
Table 77. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biomarker Testing Market Share by Type: 2020 VS 2027
Figure 2. Sepsis Biomarkers Features
Figure 3. Antibiotic Resistance Biomarkers Features
Figure 4. Traumatic Brain Injury (TBI) Testing Biomarkers Features
Figure 5. Stroke Testing Biomarkers Features
Figure 6. Antibiotic Stewardship Biomarkers Features
Figure 7. Others Features
Figure 8. Global Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Diagnostic Center Case Studies
Figure 11. Others Case Studies
Figure 12. Biomarker Testing Report Years Considered
Figure 13. Global Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 16. Global Biomarker Testing Market Share by Regions (2022-2027)
Figure 17. Global Biomarker Testing Market Share by Players in 2020
Figure 18. Global Top Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomarker Testing as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Biomarker Testing Revenue in 2020
Figure 20. Global Biomarker Testing Revenue Market Share by Type (2016-2021)
Figure 21. Global Biomarker Testing Revenue Market Share by Type (2022-2027)
Figure 22. North America Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Biomarker Testing Market Share by Type (2016-2027)
Figure 24. North America Biomarker Testing Market Share by Application (2016-2027)
Figure 25. North America Biomarker Testing Market Share by Country (2016-2027)
Figure 26. United States Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Biomarker Testing Market Share by Type (2016-2027)
Figure 30. Europe Biomarker Testing Market Share by Application (2016-2027)
Figure 31. Europe Biomarker Testing Market Share by Country (2016-2027)
Figure 32. Germany Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Biomarker Testing Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Biomarker Testing Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Biomarker Testing Market Share by Region (2016-2027)
Figure 42. China Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Biomarker Testing Market Share by Type (2016-2027)
Figure 50. Latin America Biomarker Testing Market Share by Application (2016-2027)
Figure 51. Latin America Biomarker Testing Market Share by Country (2016-2027)
Figure 52. Mexico Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Biomarker Testing Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Biomarker Testing Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Biomarker Testing Market Share by Country (2016-2027)
Figure 58. Turkey Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Agilent Technologies Revenue Growth Rate in Biomarker Testing Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Biomarker Testing Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed